| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.14▼ | 9.08▲ | 9.00▲ | 9.12▼ | 9.74▼ |
| MA10 | 9.13▼ | 8.94▲ | 8.95▲ | 9.40▼ | 10.29▼ |
| MA20 | 9.10▼ | 8.91▲ | 8.95▲ | 9.95▼ | 10.66▼ |
| MA50 | 8.93▲ | 9.05▲ | 9.35▼ | 10.85▼ | 10.75▼ |
| MA100 | 8.91▲ | 9.36▼ | 9.77▼ | 10.57▼ | 9.61▼ |
| MA200 | 8.91▲ | 9.86▼ | 9.90▼ | 10.94▼ | 8.26▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | 0.049▲ | 0.055▲ | -0.077▼ | -0.287▼ |
| RSI | 55.095▲ | 57.205▲ | 50.324▲ | 39.680▼ | 44.174▼ |
| STOCH | 54.168 | 81.435▲ | 56.567 | 15.758▼ | 38.630 |
| WILL %R | -87.097▼ | -26.471 | -26.471 | -83.816▼ | -73.504 |
| CCI | -48.605 | 116.703▲ | 154.869▲ | -99.252 | -110.306▼ |
|
Friday, May 08, 2026 09:04 AM
Announced selection of rinzimetostat RP3D in combination with darolutamide for Himalayas-1 Phase 3 global registrational trial in post-abiraterone mCRPC, expected to initiate in 1H 2026 Reported ...
|
|
Wednesday, April 08, 2026 11:07 AM
Shares of ORIC Pharmaceuticals ORIC surged more than 20% in the pre-market hours today after announcing potentially best-in-class preliminary efficacy and safety data from the ongoing early-stage ...
|
|
Tuesday, March 17, 2026 02:00 PM
Abstract HighlightsRinzimetostat is a potent and highly selective next-generation allosteric PRC2 inhibitor targeting the EED subunit that has demonstrated potential best-in-class efficacy and safety ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/05/26 | 8.79 | 9.225 | 8.79 | 9.09 | 433,760 |
| 08/05/26 | 8.80 | 9.015 | 8.715 | 8.85 | 1,258,170 |
| 07/05/26 | 9.02 | 9.06 | 8.74 | 8.81 | 1,539,632 |
| 06/05/26 | 9.67 | 9.67 | 9.15 | 9.30 | 1,270,805 |
| 05/05/26 | 9.41 | 9.64 | 9.135 | 9.57 | 2,027,499 |
| 04/05/26 | 9.70 | 10.045 | 9.50 | 9.63 | 1,053,242 |
| 01/05/26 | 9.87 | 10.125 | 9.65 | 9.77 | 1,198,580 |
| 30/04/26 | 9.50 | 9.89 | 9.40 | 9.88 | 919,794 |
| 29/04/26 | 9.51 | 9.85 | 9.235 | 9.44 | 1,341,996 |
| 28/04/26 | 10.19 | 10.46 | 9.46 | 9.65 | 1,621,920 |
|
|
||||
|
|
||||
|
|